Viral inactivation is the process of neutralizing viral contamination by exposing the bioprocess fluid to environments that denature viral proteins while preserving the active ingredient of the product. This method finds common application in blood plasma processing and monoclonal antibody processing.
The primary outcomes of viral inactivation are kits and reagents, systems, and services. The solvent detergent method is a technique that damages the lipid membrane of encapsulated viruses, leading to their inactivation. This method is frequently employed in plasma processing to safely deactivate all lipid-enveloped viruses. Viral inactivation encompasses various methods, including the solvent detergent method, pH adjustment method, pasteurization, and others. These methods are applied in vaccines and therapeutics, tissues and tissue products, blood and blood products, and various other applications. End-users of viral inactivation include pharmaceutical and biotechnology companies, contract research organizations, blood banks, hospitals, academic research institutes, and other entities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The viral inactivation market research report is one of a series of new reports from The Business Research Company that provides viral inactivation market statistics, including viral inactivation industry global market size, regional shares, competitors with a viral inactivation market share, detailed viral inactivation market segments, market trends and opportunities, and any further data you may need to thrive in the viral inactivation industry. This viral inactivation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The viral inactivation market size has grown strongly in recent years. It will grow from $5.01 billion in 2024 to $5.47 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to global air traffic growth, enhanced navigation capabilities, commercial aviation expansion, airline cost savings, improved flight safety, reduction in pilot workload.
The viral inactivation market size is expected to see rapid growth in the next few years. It will grow to $8.24 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to autonomous flight development, next-generation aircraft designs, efforts for sustainable aviation, urban air mobility (uam), increasing demand for aircraft. Major trends in the forecast period include integration of advanced avionics, implementation of artificial intelligence, human-machine interface (hmi) innovations, retrofitting existing aircraft, global navigation satellite system (gnss) integration.
The forecast of 10.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. biopharmaceutical safety by inflating prices of pathogen reduction systems and sterile filtration equipment developed in Germany and Sweden, resulting in slower blood product processing and higher transfusion service expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of various infectious diseases is expected to drive the growth of the viral inactivation market in the coming years. Infectious diseases are conditions that can be transmitted from one individual to another through contaminated food and beverages, as well as via pathogens such as viruses, bacteria, fungi, and parasites. Viral inactivation plays a crucial role in human disease-control programs by using physical and chemical disinfectants to inactivate viruses, thereby preventing the spread of contagious viral infections and contributing to the expansion of the viral inactivation market. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. The incidence rate also rose from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Thus, the increasing prevalence of various infectious diseases is fueling the growth of the viral inactivation market.
The surge in the prevalence of cancer cases is poised to drive the growth of the viral inactivation market. Cancer, characterized by the uncontrolled growth and spread of abnormal cells leading to tumor formation, necessitates treatments involving biological products. Ensuring the safety of these products through viral inactivation becomes paramount in preventing potential infections among patients undergoing cancer treatments. According to the American Cancer Society Inc., a US-based non-profit health group, the projected number of new cancer cases in the US is expected to increase from over 1,918,030 in 2022 to 1,958,310 in 2023. This escalation in cancer cases underscores the growing importance of viral inactivation in the market.
A prominent trend gaining traction in the viral inactivation market is the increased adoption of technologically advanced processes. Companies within this market are incorporating state-of-the-art technologies to maintain their competitive positions. For example, in March 2022, WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec, a China-based biopharmaceutical company, introduced the Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology. This cutting-edge approach facilitates the approval of new therapies by concurrently conducting all assay formulation, biosafety, viral clearance, product release, and testing in-house. TESSA Technology represents an innovative method for producing adeno-associated virus (AAV) at Good Manufacturing Practices (GMP) grade without the need for transfection.
Major players in the viral inactivation market are focusing on the development of groundbreaking products, such as non-hazardous viral inactivation mediums, to gain a competitive edge. Non-hazardous viral inactivation mediums are formulations designed to inactivate viruses in laboratory or clinical settings without posing risks or hazards to individuals handling the samples. Thermo Fisher Scientific Inc., a US-based biotechnology company, exemplified this approach in March 2022 with the launch of the InhibiSURE Viral Inactivation Medium. This breakthrough formulation is specifically designed for the safe collection and transport of the SARS-CoV-2 virus, ensuring rapid inactivation and stabilization of viral RNA at ambient temperature. The medium eliminates potential hazards associated with traditional inactivation media, enhancing laboratory safety and contributing to a secure and efficient sample collection and transport process.
In June 2022, Asahi Kasei Medical, a Japan-based healthcare company specializing in chemical manufacturing, acquired Bionova Scientific for an undisclosed amount. This acquisition provides Asahi Kasei access to Bionova's 36,000-square-foot production facility equipped with two 2,000-litre mammalian cell culture trains. The facility has the capacity to produce various monoclonal antibodies and other recombinant proteins. Post-acquisition, Asahi Kasei aims to leverage its existing businesses in bioprocess supplies, tools, biosafety testing services, and the biologics CDMO division of Bionova Scientific. Bionova Scientific, a US-based company, is engaged in the cGMP manufacturing of biologics and downstream purification processes for viral inactivation and viral filtration.
Major companies operating in the viral inactivation market include Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation And Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited
North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the viral inactivation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The viral inactivation market includes revenues earned by chemical viral inactivation and radiation viral inactivation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Viral Inactivation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on viral inactivation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for viral inactivation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral inactivation market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Kits And Reagents; Systems; Services
- 2) By Method: Solvent Detergent Method; pH Adjustment Method; Pasteurization; Other Methods
- 3) By Application: Vaccines And Therapeutics; Tissues And Tissue Products; Blood And Blood Products; Other Applications
- 4) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Blood Banks; Hospital; Academic Research Institutes; Other End Users
- Subsegments:
- 1) By Kits And Reagents: Viral Inactivation Kits; PCR Reagents; Antibodies and Enzymes
- 2) By Systems: Automated Viral Inactivation Systems; Batch Viral Inactivation Systems; Continuous Flow Systems
- 3) By Services: Viral Testing Services; Validation Services; Consulting Services
- Companies Mentioned: Merck & Co. Inc.; Sartorius AG; Texcell SA; SGS SA; Charles River Laboratories Inc.; Clean Cells SAS; Rad Source Technologies; WuXi AppTec; Sigma-Aldrich Co. LLC; Thermo Fisher Scientific Inc.; Macopharma; Cerus Corporation; TERUMO BCT INC.; Shandong Weigao Group Medical Polymer Co. Ltd.; Pall Corporation And Eurofins Scientific; General Electric Company; Cytiva; Mettler Toledo; Viral Inactivated Plasma Systems SA; Eurofins Scientific SE; Lonza Group AG; Avantor Inc.; Bio-Rad Laboratories Inc.; F. Hoffmann-La Roche AG; Fujifilm Holdings Corporation; Pfizer Inc.; Novartis AG; Gilead Sciences Inc.; Johnson & Johnson Private Limited
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Viral Inactivation Market Characteristics
3. Viral Inactivation Market Trends And Strategies
4. Viral Inactivation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Viral Inactivation Growth Analysis And Strategic Analysis Framework
- 5.1. Global Viral Inactivation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Viral Inactivation Market Growth Rate Analysis
- 5.4. Global Viral Inactivation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Viral Inactivation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Viral Inactivation Total Addressable Market (TAM)
6. Viral Inactivation Market Segmentation
- 6.1. Global Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Kits And Reagents
- Systems
- Services
- 6.2. Global Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Solvent Detergent Method
- pH Adjustment Method
- Pasteurization
- Other Methods
- 6.3. Global Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Vaccines And Therapeutics
- Tissues And Tissue Products
- Blood And Blood Products
- Other Applications
- 6.4. Global Viral Inactivation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmaceutical And Biotechnology Companies
- Contract Research Organizations
- Blood Banks
- Hospital
- Academic Research Institutes
- Other End Users
- 6.5. Global Viral Inactivation Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Viral Inactivation Kits
- PCR Reagents
- Antibodies and Enzymes
- 6.6. Global Viral Inactivation Market, Sub-Segmentation Of Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Automated Viral Inactivation Systems
- Batch Viral Inactivation Systems
- Continuous Flow Systems
- 6.7. Global Viral Inactivation Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Viral Testing Services
- Validation Services
- Consulting Services
7. Viral Inactivation Market Regional And Country Analysis
- 7.1. Global Viral Inactivation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Viral Inactivation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Viral Inactivation Market
- 8.1. Asia-Pacific Viral Inactivation Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Viral Inactivation Market
- 9.1. China Viral Inactivation Market Overview
- 9.2. China Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Viral Inactivation Market
- 10.1. India Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Viral Inactivation Market
- 11.1. Japan Viral Inactivation Market Overview
- 11.2. Japan Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Viral Inactivation Market
- 12.1. Australia Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Viral Inactivation Market
- 13.1. Indonesia Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Viral Inactivation Market
- 14.1. South Korea Viral Inactivation Market Overview
- 14.2. South Korea Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Viral Inactivation Market
- 15.1. Western Europe Viral Inactivation Market Overview
- 15.2. Western Europe Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Viral Inactivation Market
- 16.1. UK Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Viral Inactivation Market
- 17.1. Germany Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Viral Inactivation Market
- 18.1. France Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Viral Inactivation Market
- 19.1. Italy Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Viral Inactivation Market
- 20.1. Spain Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Viral Inactivation Market
- 21.1. Eastern Europe Viral Inactivation Market Overview
- 21.2. Eastern Europe Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Viral Inactivation Market
- 22.1. Russia Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Viral Inactivation Market
- 23.1. North America Viral Inactivation Market Overview
- 23.2. North America Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Viral Inactivation Market
- 24.1. USA Viral Inactivation Market Overview
- 24.2. USA Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Viral Inactivation Market
- 25.1. Canada Viral Inactivation Market Overview
- 25.2. Canada Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Viral Inactivation Market
- 26.1. South America Viral Inactivation Market Overview
- 26.2. South America Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Viral Inactivation Market
- 27.1. Brazil Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Viral Inactivation Market
- 28.1. Middle East Viral Inactivation Market Overview
- 28.2. Middle East Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Viral Inactivation Market
- 29.1. Africa Viral Inactivation Market Overview
- 29.2. Africa Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Viral Inactivation Market Competitive Landscape And Company Profiles
- 30.1. Viral Inactivation Market Competitive Landscape
- 30.2. Viral Inactivation Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Texcell SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. SGS SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Charles River Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Viral Inactivation Market Other Major And Innovative Companies
- 31.1. Clean Cells SAS
- 31.2. Rad Source Technologies
- 31.3. WuXi AppTec
- 31.4. Sigma-Aldrich Co. LLC
- 31.5. Thermo Fisher Scientific Inc.
- 31.6. Macopharma
- 31.7. Cerus Corporation
- 31.8. TERUMO BCT INC.
- 31.9. Shandong Weigao Group Medical Polymer Co. Ltd.
- 31.10. Pall Corporation
- 31.11. Eurofins Scientific
- 31.12. General Electric Company
- 31.13. Cytiva
- 31.14. Mettler Toledo
- 31.15. Viral Inactivated Plasma Systems SA
32. Global Viral Inactivation Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Viral Inactivation Market
34. Recent Developments In The Viral Inactivation Market
35. Viral Inactivation Market High Potential Countries, Segments and Strategies
- 35.1 Viral Inactivation Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Viral Inactivation Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Viral Inactivation Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
